VetMedGuide

Vet Med Guide

Pharmaceuticals2026-05-17 · 11 min read

Gabapentin for Dogs: What It Treats, What the Evidence Shows, What Owners Should Watch For

An evidence-based guide to gabapentin for dogs: how it is used for chronic pain, anxiety, and seizures, what the research actually shows, and when to ask questions before filling the prescription.

Ran Chen
Ran Chen
Founder, VetMedGuide. Life-sciences operator and 10× global market-access lead.
Published

Gabapentin (Neurontin and generics) is one of the most widely prescribed off-label medications in veterinary medicine. Originally developed as an anticonvulsant for humans, it has become a mainstay in veterinary practice for three reasons: chronic pain management, situational anxiety, and adjunct seizure control.

It is not FDA-approved for use in any animal species. Every prescription written for a dog is off-label — meaning the veterinarian has determined that the potential benefits for the individual patient outweigh the limitations of the available evidence.

This article covers the three main veterinary uses, what peer-reviewed research and clinical guidelines actually say about efficacy, how side effects present in dogs, and what owners should discuss with their veterinarian before and during treatment.

How gabapentin works (and what it does not do)

Gabapentin is a structural analog of the inhibitory neurotransmitter GABA (gamma-aminobutyric acid). Despite this structural similarity, gabapentin does not bind to GABA receptors. Instead, it binds to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, reducing the release of excitatory neurotransmitters.

In plain terms: gabapentin dampens abnormal nerve signaling. This mechanism explains why it is most useful for neuropathic pain (pain originating from nerve damage or nerve dysfunction) and why it has anxiolytic and sedative properties — but it also explains why it is not a general-purpose painkiller.

It does not reduce inflammation. It does not treat the underlying cause of pain, seizures, or anxiety. It modulates how the nervous system processes those signals.

Use 1: Chronic and neuropathic pain

This is the most common reason veterinarians prescribe gabapentin for dogs.

Osteoarthritis pain

The 2022 AAHA Pain Management Guidelines for Dogs and Cats list gabapentin as a second-tier pharmacological option for chronic osteoarthritis pain — meaning it is recommended when first-tier treatments (NSAIDs and anti-NGF monoclonal antibodies like Librela) alone are not sufficient, or when those drugs are contraindicated.

Gabapentin is rarely prescribed alone for arthritis pain. It is typically added to an NSAID (such as carprofen, meloxicam, or grapiprant) or to Librela as part of a multimodal pain plan. The logic is that combining drugs with different mechanisms can provide better pain control than any single drug.

However, the evidence specific to gabapentin for canine osteoarthritis pain is limited. A retrospective study of 240 dogs receiving gabapentin for chronic pain found it to be well tolerated across a wide range of doses, but rigorous placebo-controlled trials demonstrating clear analgesic benefit in OA are sparse. This is an honest limitation of the current evidence: many veterinarians observe clinical improvement, but the published data are not as strong as the evidence supporting NSAIDs.

Neuropathic and cancer pain

Gabapentin is more convincingly useful for neuropathic pain — pain caused by nerve compression, nerve damage, or abnormal nerve signaling. Examples include:

  • Intervertebral disc disease (IVDD) and spinal cord compression
  • Post-amputation phantom limb pain
  • Nerve-root tumors or masses compressing nerves
  • Post-surgical neuropathic pain

In these scenarios, gabapentin may address a pain component that NSAIDs do not reach, because NSAIDs target inflammation while gabapentin targets abnormal nerve firing.

Post-surgical pain

Gabapentin is sometimes prescribed after orthopedic or spinal surgery as part of a multimodal analgesic protocol. The 2022 AAHA guidelines support this practice, placing gabapentin in the second tier of options alongside amantadine and acetaminophen for acute pain management when first-line drugs are insufficient.

Use 2: Anxiety and situational stress

Gabapentin has become the most commonly prescribed medication for veterinary visit anxiety in dogs and cats. It is also used for:

  • Thunderstorm and fireworks phobia
  • Separation anxiety (usually as an adjunct, not a standalone treatment)
  • Generalized anxiety that does not respond to behavior modification alone
  • Pre-visit sedation for fearful patients

A 2025 systematic review published in Veterinary Sciences (MDPI) focused on feline patients found that gabapentin reliably induces sedation and reduces stress-related behaviors in cats during veterinary examinations. While the feline evidence is the most systematically reviewed, clinical experience and the pharmacological mechanism support similar sedative and anxiolytic effects in dogs — a calmer dog is easier to examine and less likely to experience escalated fear.

Important context: gabapentin is not a behavior modification drug in the sense that fluoxetine (Reconcile) or clomipramine (Clomicalm) are. It does not treat the underlying anxiety disorder. It reduces the physiological arousal response in the moment. For chronic behavioral conditions, it is typically combined with a dedicated behavior modification plan and sometimes with a daily SSRI or TCA.

Gabapentin vs trazodone for anxiety

Both drugs are commonly prescribed for situational anxiety, but they work differently:

Feature Gabapentin Trazodone
Drug class Calcium channel modulator Serotonin antagonist and reuptake inhibitor (SARI)
Primary mechanism Dampens nerve excitability Increases serotonin activity
Onset 1–2 hours 1–2 hours
Main effect Sedation, reduced arousal Sedation, anxiolysis
Common use Vet visit anxiety, neuropathic pain Post-surgical rest, generalized anxiety, noise phobia
Key side effect Sedation, ataxia Sedation, GI upset, rare serotonin syndrome

Veterinarians may choose one over the other based on the specific scenario, or combine both for severely anxious patients. The choice should involve a discussion with the prescribing veterinarian about the dog's specific triggers and health history.

Use 3: Seizure management

Gabapentin was originally developed as an anticonvulsant, and it is sometimes used as an adjunct (add-on) medication for dogs with epilepsy that is not adequately controlled by first-line anticonvulsants such as phenobarbital, potassium bromide, or levetiracetam (Keppra).

It is not considered a first-line anticonvulsant for dogs. The evidence for seizure control in veterinary patients is limited compared to the established anticonvulsants. When it is used for seizures, it is almost always in combination with other drugs, not as monotherapy.

Dosing considerations

Gabapentin dosing in dogs is entirely off-label, and there is no single "standard dose." Veterinarians select the dose based on the condition being treated, the dog's weight, kidney function, and concurrent medications.

General dosing ranges reported in veterinary literature and clinical practice:

  • Chronic pain: often started at 5–10 mg/kg every 8–12 hours and titrated based on response.
  • Anxiety/situational use: often dosed higher per administration (10–20 mg/kg) given 1–2 hours before the triggering event.
  • Seizures: variable, typically initiated at the lower end and adjusted based on seizure frequency.

Dosing is further complicated by the available formulations. Human gabapentin capsules and tablets come in sizes that may not match the target veterinary dose, requiring owners to split tablets or compound the medication. The 50 mg/mL oral solution can help with small dogs and precise dosing.

Critical warning: xylitol in liquid gabapentin

Many commercially available liquid gabapentin formulations made for humans contain xylitol (also labeled as "sorbitol" in some products), an artificial sweetener that is extremely toxic to dogs and can cause life-threatening hypoglycemia and liver failure at relatively small doses. Before giving any liquid gabapentin formulation to your dog, confirm with your pharmacist or veterinarian that it is xylitol-free. This is one reason many veterinarians prefer to prescribe gabapentin capsules or have the medication compounded at a veterinary pharmacy.

Renally impaired dogs may require dose reduction, because gabapentin is excreted primarily by the kidneys. Veterinarians often check baseline kidney values before starting long-term gabapentin in senior dogs.

Side effects and monitoring

Sedation and ataxia (most common)

The most frequently reported side effects are sedation (drowsiness, lethargy) and ataxia (wobbly or uncoordinated gait). These effects are dose-dependent and are usually most pronounced after the first few doses or after a dose increase. In many dogs, tolerance develops over several days to a week.

If sedation is severe enough that the dog cannot stand, walk to food or water, or go outside to eliminate, the dose needs adjustment. Do not change the dose on your own — call your veterinarian.

Gastrointestinal effects

Vomiting and diarrhea can occur but are less common than sedation. Giving gabapentin with food may reduce GI upset.

Discontinuation

Gabapentin should not be stopped abruptly, especially in dogs taking it for seizures or chronic pain. Sudden discontinuation can cause rebound pain or, in seizure patients, potentially trigger breakthrough seizures. If the medication needs to be stopped, veterinarians typically taper the dose gradually over several days to weeks.

Kidney function

Because gabapentin is cleared renally, dogs with decreased kidney function may accumulate the drug, leading to stronger or prolonged sedation. Senior dogs and those with known kidney disease should have renal values monitored during long-term treatment.

Interactions

Gabapentin can compound the sedative effects of other central nervous system depressants, including trazodone, acepromazine, opioid pain medications, and certain antihistamines. This is sometimes intentional (as in multimodal protocols for anxious patients) but should be managed by the prescribing veterinarian. Gabapentin given before anesthesia may require a dose adjustment — tell your veterinarian if your dog is taking gabapentin before any surgical or dental procedure.

What the evidence actually shows

An honest assessment of gabapentin in veterinary medicine requires acknowledging both its widespread use and the limits of the evidence:

  • Evidence is stronger for: sedation/anxiolysis (veterinary visits, situational anxiety), neuropathic pain conditions, and multimodal adjunctive use in chronic pain protocols.
  • Evidence is weaker for: gabapentin as a standalone analgesic for osteoarthritis, and seizure control as monotherapy. Many veterinarians report clinical improvement, but well-designed placebo-controlled trials are limited.
  • A 2021 review on the SkeptVet blog noted that gabapentin's widespread adoption in veterinary pain management may outpace the strength of the evidence — similar to what happened with tramadol, which was extensively prescribed before rigorous studies showed minimal analgesic benefit in dogs. This does not mean gabapentin is ineffective, but it does mean owners should have realistic expectations and ensure the treatment plan includes objective reassessment.

The 2022 AAHA Pain Management Guidelines place gabapentin in the second tier of pharmacological options, not the first. This is a deliberate ranking that reflects both clinical utility and evidence strength.

When gabapentin may not be the right choice

  • As the sole pain medication for osteoarthritis. NSAIDs or Librela should generally be tried first unless contraindicated. Gabapentin is best viewed as an add-on, not a replacement.
  • In dogs with severe kidney disease. Dose reduction and closer monitoring are required. In advanced renal failure, the accumulation risk may outweigh benefits.
  • When sedation is unacceptable. Working dogs, dogs with mobility issues that make ataxia dangerous (such as dogs prone to falling on hard floors), and dogs that cannot afford further sedation alongside other CNS-depressing medications may not be good candidates.
  • As a replacement for behavioral intervention. For chronic anxiety disorders, medication alone is rarely as effective as medication combined with a structured behavior modification plan. Gabapentin manages the moment; it does not treat the underlying behavioral condition.

What to ask your veterinarian

  • What is the goal of adding gabapentin? Is it replacing another medication, adding to an existing plan, or being used for a specific situation (like vet visits)? The answer should be clear.
  • How will we know if it is working? Pain and anxiety are subjective. Ask your veterinarian what specific signs to track — activity level, willingness to walk stairs, tolerance of handling, visit behavior — and when to report back.
  • What dose increases or decreases should I expect? Gabapentin is often titrated. Know the starting dose, the maximum dose your vet considers safe, and the schedule for adjustments.
  • How do I handle missed doses? The answer depends on the reason gabapentin was prescribed. For chronic pain, the approach differs from situational anxiety use.
  • Should this be combined with anything else? Gabapentin is almost always part of a larger plan. Ask what other medications, supplements, diet changes, physical therapy, or behavioral strategies should accompany it.

Sources

Topics
Anesthesia & Analgesia
Related Articles